MEGAN BOOSE: Open Payments
NPI 1295069664 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 46 payments from 15 companies in 2025. Trend: 2023 $1,223 · 2024 $1,048 · 2025 $1,157
Food & beverage: $982Education: $175
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $306 |
| UCB, Inc. | 3 | $179 |
| Lilly USA, LLC | 14 | $168 |
| REVANCE THERAPEUTICS, INC. | 2 | $112 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| GENZYME CORPORATION | 2 | $37 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| MIMEDX Group, Inc. | 2 | $34 |
| Galderma Laboratories, L.P. | 1 | $27 |
Products named: TREMFYA, Bimzelx, DAXXIFY, EBGLYSS, Sotyktu, TALTZ, DUPIXENT, Zoryve.
Industry payments across ND — which companies pay providers there.
